Ark Genomic Revolution Etf Performance
| ARKG Etf | USD 23.32 0.46 2.01% |
The etf shows a Beta (market volatility) of -0.17, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning ARK Genomic are expected to decrease at a much lower rate. During the bear market, ARK Genomic is likely to outperform the market.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in ARK Genomic Revolution are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable forward-looking signals, ARK Genomic is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| In Threey Sharp Ratio | -0.44 |
ARK |
ARK Genomic Relative Risk vs. Return Landscape
If you would invest 2,418 in ARK Genomic Revolution on December 24, 2024 and sell it today you would lose (9.00) from holding ARK Genomic Revolution or give up 0.37% of portfolio value over 90 days. ARK Genomic Revolution is currently generating 0.0406% in daily expected returns and assumes 3.084% risk (volatility on return distribution) over the 90 days horizon. In different words, 27% of etfs are less volatile than ARK, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ARK Genomic Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ARK Genomic's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as ARK Genomic Revolution, and traders can use it to determine the average amount a ARK Genomic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0132
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ARKG |
Estimated Market Risk
| 3.08 actual daily | 27 73% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 1 99% of assets perform better |
Based on monthly moving average ARK Genomic is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ARK Genomic by adding it to a well-diversified portfolio.
ARK Genomic Fundamentals Growth
ARK Etf prices reflect investors' perceptions of the future prospects and financial health of ARK Genomic, and ARK Genomic fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ARK Etf performance.
| Price To Earning | 41.86 X | |||
| Price To Book | 3.26 X | |||
| Price To Sales | 7.63 X | |||
| Total Asset | 2.36 B | |||
About ARK Genomic Performance
By analyzing ARK Genomic's fundamental ratios, stakeholders can gain valuable insights into ARK Genomic's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ARK Genomic has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ARK Genomic has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
The fund is an actively-managed exchange-traded fund that will invest under normal circumstances primarily in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the funds investment theme of the genomics revolution . Ark Genomic is traded on BATS Exchange in the United States.| ARK Genomic had very high historical volatility over the last 90 days | |
| ARK Genomic Revolution created five year return of -3.0% | |
| This fund holds 99.63% of its assets under management (AUM) in equities |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ARK Genomic Revolution. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
The market value of ARK Genomic Revolution is measured differently than its book value, which is the value of ARK that is recorded on the company's balance sheet. Investors also form their own opinion of ARK Genomic's value that differs from its market value or its book value, called intrinsic value, which is ARK Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ARK Genomic's market value can be influenced by many factors that don't directly affect ARK Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ARK Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if ARK Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ARK Genomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.